Skip to main content

Advertisement

SpringerLink
Log in

Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Agomelatine, an antidepressant with melatonin agonist and 5-HT2C antagonist properties, as well as two of its main metabolites, S 21517 (N-[2-(7-hydroxy-1-naphtyl)ethyl]acetamide) and S21540 (N-[2-(3-hydroxy-7-methoxynaphtalen-1-yl)ethyl]acetamide), have been assessed in vitro on pig choroid plexus preparations to determine their affinities for 5-HT2C receptors and their effects on inositol phosphate production. These compounds were also tested for their ability to inhibit the penile erections induced by the 5-HT2C receptor agonists, m-(chlorophenyl)piperazine (mCPP, 0.75 mg/kg, SC) and Ro 60-0175 (2.5 mg/kg, SC) in Wistar rats. These in vivo effects were compared to those of melatonin and the 5-HT antagonists pizotifen and SB 206,553. Agomelatine and S 21517 had moderate affinity for 5-HT2C receptors and behaved in vitro as weak antagonists at this receptor subtype. S 21540 had a 10-fold lower affinity. Pizotifen and SB 206,553 antagonized mCPP- and Ro 60-0175-induced penile erections, suggesting that penile erections induced by mCPP or Ro 60-0175 resulted from the stimulation of 5-HT2C receptors. Whereas increasing doses (from 1.25 to 40 mg/kg, IP) of melatonin were unable to modify the penile erections induced by mCPP and Ro 60-0175, agomelatine (from 1.25 to 40 mg/kg, IP) dose-dependently decreased mCPP- as well Ro 60-0175-induced penile erections. Furthermore, increasing doses (from 1.25 to 40 mg/kg, IP) of S 21517 and S 21540, the two main metabolites of agomelatine, did not affect the penile erections induced by mCPP and Ro 60-0175. Considering the similar activity of melatonin and agomelatine at melatonin receptors, these data suggested that the reported effects were not due to the stimulation of melatonin receptors and that, contrary to melatonin, agomelatine exerted 5-HT2C receptor antagonist properties in addition to its agonist activity at melatonin receptors. Finally, neither S 21517 nor S 21540 seemed to participate to the observed inhibition of penile erections by agomelatine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  • Armstrong SM, McNulty OM, Guardiola-Lemaître B, Redman JR (1993) Successful use of S 20098 and melatonin in a animal model of delayed sleep-phase syndrome. Pharmacol Biochem Behav 46:45–49

    Article  CAS  PubMed  Google Scholar 

  • Berendsen HHG, Jenk F, Broekkamp CLE (1990) Involvement of 5-HT1C receptors in drug-induced penile erections in rats. Psychopharmacology 101:57–61

    CAS  PubMed  Google Scholar 

  • Bertaina-Anglade V, Mocaër E, Drieu la Rochelle (2002) Antidepressant-like action of S 20098 (agomelatine) in the learned helplessness test. Int J Neuropsychopharmacol 5:S65

    Google Scholar 

  • Bourin M, Mocaër E, Porsolt R (2002) Efficacy and behavioral profile of S20098 in the despair test after acute and repeated administration. XXIII C.I.N.P. Congress, Collegium International Neuropsychopharmacology, June 23–27 Montréal (Canada)

  • Conway S, Canning SJ, Howell E, Mowat ES, Barrett P, Drew JE, Delagrange P, Lesieur D, Morgan PJ (2000) Characterisation of human melatonin mt1 and MT2 receptors by CRE-luciferase reporter assay. Eur J Pharmacol 390:15–24

    Article  CAS  PubMed  Google Scholar 

  • Grassi-Zucconi G, Semprevivo M, Mocaër E, Kristensson K, Bentivoglio M (1996) Melatonin and its new agonist S 20098 restore synchonized sleep fragmented by experimental trypanosome infection in the rat. Brain Res Bull 39:63–68

    Article  CAS  PubMed  Google Scholar 

  • Hoyer D, Waeber C, Schoeffter P, Palacios JM, Dravid A (1989) 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Naunyn-Schmiedeberg's Arch Pharmacol 339:252–258

    Google Scholar 

  • Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233–236

    Article  CAS  PubMed  Google Scholar 

  • Jenck F, Moreau JL, Mutel V, Martin JR, Haefely WE (1993) Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223–229

    CAS  PubMed  Google Scholar 

  • Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP (1996) In vitro and in vivo profile of SB 206,553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Br J Pharmacol 117:427–434

    CAS  PubMed  Google Scholar 

  • Lôo H, Hale A, D'Haenen H (2002) Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol 17:239–247

    PubMed  Google Scholar 

  • Martin JR, Bös M, Jenck F, Moreau JL, Mutel V, Sleight AJ, Wichmann J, Andrews JS, Berendsen HHG, Broekkamp CLE, Ruigt GSF, Köhler C, van Delft AML (1998) 5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential. J Pharmacol Exp Ther 286:913–924

    CAS  PubMed  Google Scholar 

  • Martinet L, Guardiola-Lemaître B, Mocaër E (1996) Entrainment of circadian rhythms by S 20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol Biochem Behav 54:713–718

    Article  CAS  PubMed  Google Scholar 

  • Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S (1997) 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Eur J Pharmacol 325:9–12

    CAS  PubMed  Google Scholar 

  • Palvimaki EP, Roth BL, Majasuo H, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J (1996) Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor. Psychopharmacology 126:234–240

    PubMed  Google Scholar 

  • Papp M, Gruca P, Boyer PA, Mocaer E (2003) Effect of S 20098 (agomelatine) in the chronic mild stress model of depression in the rat; comparison with melatonin, imipramine and fluoxetine. Neurospychopharmacology 28:694–703

    Google Scholar 

  • Pazos A, Hoyer D, Palacios JM (1984) The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539–546

    Article  CAS  PubMed  Google Scholar 

  • Protais P, Dubuc I, Costentin J (1983) Pharmacological charactersitics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats. Eur J Pharmacol 94:271–280

    PubMed  Google Scholar 

  • Protais P, Windsor M, Mocaër E, Comoy E (1995) Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats. Psychopharmacology 120:376–383

    CAS  PubMed  Google Scholar 

  • Redman JR, Francis AJP (1998) Entrainment of rat circadian rhythms by the melatonin agonist S 20098 requires intact suprachiasmatic nuclei but not the pineal. J Biol Rhythms 13:39–51

    CAS  PubMed  Google Scholar 

  • Redman JR, Guardiola-Lemaître B, Brown M, Delagrange P, Armstrong SM (1995) Dose-dependent effects of S 20098, a melatonin agonist on direction of reentrainment of rat circadian rhythms. Psychopharmacology 118:385–390

    CAS  PubMed  Google Scholar 

  • Staner L, Kempenaers C, Simonnet MP, Fransolet L, Mendlewicz J (1992) 5-HT2 receptor antagonism and slow-wave sleep in major depression. Acta Psychiatr Scand 86:133–137

    CAS  PubMed  Google Scholar 

  • Strauss WH, Klieser E (1991) Psychotropic effects of ritanserin, a selective S2 antagonist: an open study. Eur Neuropsychopharmacol 1:101–105

    CAS  PubMed  Google Scholar 

  • Van Reeth O, Olivares Y, Zhang FW, Turek FW, Defrance R, Mocaer E (1997) Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters. Brain Res 762:185–194

    Article  PubMed  Google Scholar 

  • Van Reeth O, Weibel L, Olivares E, Maccari S, Mocaër E, Turek FW (2001) Melatonin or a melatonin agonist correct age-related changes in circadian response to an environmental stimulus. Am J Physiol 280:1582–1591

    Google Scholar 

  • Weibel L, Turek FW, Mocaër E, Van Reeth O (2000) A melatonin agonist facilitates circadian resynchonization in old hamsters after abrupt shifts in the light-dark cycle. Brain Res 880:207–211

    Article  CAS  PubMed  Google Scholar 

  • Wiley JL, Dance ME, Balster RL (1998) Preclinical evaluation of the reinforcing and discriminative stimulus effects of agomelatine (S 20098), a melatonin agonist. Psychopharmacology 140:503–509

    Article  CAS  PubMed  Google Scholar 

  • Ying AS, Rusak B, Delagrange P, Mocaer E, Renard P, Guardiola-Lemaitre B (1996) Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol 296:33–42

    Article  CAS  PubMed  Google Scholar 

  • Yous S, Andrieux HE, Howell PJ, Morgan P, Renard B, Pfeiffer D, Lesieur B (1992) Novel naphtalenic ligands with affinity for the melatonin receptor. J Med Chem 35:1484–1485

    CAS  PubMed  Google Scholar 

  • Zifa E, Fillion G (1992) 5-Hydroxytryptamine receptors. Pharmacol Rev 44:401–458

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire de Physiologie (VACOMED), U.F.R. de Médecine-Pharmacie, 22 Boulevard Gambetta, 76183, Rouen Cedex 1, France

    Abdeslam Chagraoui & Philippe Protais

  2. MDS Pharma Services, 18 Chemin des Aulx, 1228, Plan-les-Ouates, Geneva, Switzerland

    Thierry Filloux

  3. Institut de Recherches Internationales Servier, IRIS, 6 Place des Pléiades, 92415, Courbevoie Cedex, France

    Elisabeth Mocaër

Authors
  1. Abdeslam Chagraoui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philippe Protais
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thierry Filloux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elisabeth Mocaër
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abdeslam Chagraoui.

Additional information

Dr. Protais died in 2002

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chagraoui, A., Protais, P., Filloux, T. et al. Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT2C receptors in Wistar rats. Psychopharmacology 170, 17–22 (2003). https://doi.org/10.1007/s00213-003-1465-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1465-3

Keywords

Search

Navigation